LD-2 disclosure · 3rd Quarter - Report
GVB BIOPHARMA
Client
- Name
- GVB BIOPHARMA
- Description
- CBD extraction and distillation
- Location
- Nevada · United States of America
Registrant
- Description
- Government relations and business consulting
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueAgriculture
H.R.841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 (All sections of full text) Discussions relating to regulation of the CBD industry. Monitored discussions relating to regulation of Delta-8 THC. Monitored regulations on hemp/CBD issues. Monitored S. 253 Cannabidiol and Marihuana Research Expansion Act.
Lobbyistsmr JACK S DEUSER jr · mr IAN S.D. MAIR · TREVOR W. KOLEGO · MICHAEL A. GAFFIN
Covered position (MICHAEL A. GAFFIN): Leg. Director, Sen. Sherrod Brown; Leg. Director, Rep. Rob Andrews; Leg. Asst., Rep. Anna Eshoo; Jr. Leg. Assoc., House Ed. and Labor Committee, Rep. George Miller; Staff Asst., Senate HELP Committee, Sen. Edward Kennedy
TargetedHOUSE OF REPRESENTATIVES